Tomoyuki Yamasaki

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 309 citations

Medicine, Cardiology, Internal Medicine +13

Regulation of Phosphoenolpyruvate Carboxykinase and Insulin-like Growth Factor-binding Protein-1 Gene Expression by Insulin

Robert K. Hall, Tomoyuki Yamasaki, Tomáš Kučera et al. · Journal of Biological Chemistry · 2000 · 283 citations · Full text

Life Sciences, Genetics, Molecular Biology +13

Hepatic Nuclear Factor 3- and Hormone-Regulated Expression of the Phosphoenolpyruvate Carboxykinase and Insulin-Like Growth Factor-Binding Protein 1 Genes

Richard M. O’Brien, Edouard L. Noisin, Adisak Suwanichkul et al. · Molecular and Cellular Biology · 1995 · 227 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +14

Cloning of human muscle phosphofructokinase cDNA

Hiromu Nakajima, Tamio Noguchi, Tomoyuki Yamasaki et al. · FEBS Letters · 1987 · 71 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

The utility of nutritional supportive care with an eicosapentaenoic acid (EPA)-enriched nutrition agent during pre-operative chemoradiotherapy for pancreatic cancer: Prospective randomized control study

Hirofumi Akita, Hidenori Takahashi, Kei Asukai et al. · Clinical Nutrition ESPEN · 2019 · 53 citations

Medicine, Nutrition, Oncology +17